Indian Company Master Data Made Simple
Search:
MCA
GSTIN
LEI
Udyam
Directors
36+ lakh companies in our registry
Venmax Drugs And Pharmaceuticals Limited
Incorporated in 1988, Venmax Drugs And Pharmaceuticals Limited has a history spanning 3 decades. Its CIN is L24230TG1988PLC009102, with registration number 9102. The organization is recorded as company limited by shares under Indian company law. Venmax Drugs And Pharmaceuticals Limited’s authorized capital amounts to ₹22.00 crore. The paid-up share capital amounts to ₹8.01 crore.
The main line of business is manufacture of chemicals and chemical products. The company’s registration location is Hyderabad. Its registered address is Sy. No. 115, Brig Sayeed Road, Hanumanji Colony, Bowenpally, Picket, Hyderabad, Secunderabad, Telangana, India, 500009. The firm continues to be in active status. The company’s Permanent Account Number (PAN) is AAACY1073C. Its primary communication email is venmaxdrugs@gmail.com. Senior management roles are held by Sai Baba Kummarikuntla (CFO) and Sai Baba Kummarikuntla (CFO).
Company Overview
- CIN
- Date of Incorporation
- 28/09/1988
- Company Status
- Active
- RoC
- Hyderabad
- Registration Number
- Balance sheet date
- 31/03/2025
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- Authorized Capital
- ₹22,00,00,000.00
- Paid up Capital
- ₹8,00,79,300.00
- Activity
- Manufacture Of Chemicals And Chemical Products
- venmaxdrugs@gmail.com
- PAN
GST Numbers
| State | GST Number | Status |
|---|---|---|
| Andhra Pradesh | 37AAACY1073C1ZM | Inactive |
| Telangana | 36AAACY1073C1ZO | Inactive |
| 36AAACY1073C2ZN | Inactive | |
| 36AAACY1073C3ZM | Active |
ISIN Numbers
| ISIN | Security | Interest Rate | Maturity Date | FISN | CFI |
|---|---|---|---|---|---|
| IN8154G01013 | VENMAX DRUGS AND PHARMACEUTICALS LIMITED EQ LISTING/TRADING APPROVAL AWAITED | - | 12/10/2026 | VENMAX DRUGS/SH VTG | ESVUFN |
| INE154G01022 | VENMAX DRUGS AND PHARMACEUTICALS LIMITED EQ | - | 12/10/2026 | VENMAX DRUGS/SH VTG | ESVUFN |
| INE154G13019 | VENMAX DRUGS AND PHARMACEUTICALS LIMITED WARRANTS 20SP26 | - | 20/09/2026 | VENMAX DRUGS/WT 20260920 | RWSTBA |
Balance Sheet
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Net PPE | ₹3.65L | ₹4.05L | ₹4.50L | ₹5.00L | ₹0.00L |
| Inventory | ₹99.88L | ₹5.75L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Debt | ₹33.09L | ₹4.96L | ₹35.21L | ₹35.21L | ₹0.00L |
| Common Stock | ₹1,158.29L | ₹523.89L | ₹523.89L | ₹523.89L | ₹0.00L |
| Current Debt | ₹28.13L | ₹4.96L | ₹35.21L | ₹35.21L | ₹0.00L |
| Share Issued | ₹115.83L | ₹52.39L | ₹52.39L | ₹52.39L | ₹0.00L |
| Total Assets | ₹1,620.02L | ₹516.96L | ₹8.14L | ₹21.14L | ₹0.00L |
| Capital Stock | ₹1,158.29L | ₹523.89L | ₹523.89L | ₹523.89L | ₹0.00L |
| Long Term Debt | ₹4.96L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Current Assets | ₹1,616.36L | ₹512.92L | ₹1.56L | ₹13.84L | ₹0.00L |
| Working Capital | ₹1,413.06L | ₹437.25L | -₹71.13L | -₹78.28L | ₹0.00L |
| Invested Capital | ₹1,444.71L | ₹446.15L | -₹29.80L | -₹36.24L | ₹0.00L |
| Common Stock Equity | ₹1,411.62L | ₹441.19L | -₹65.01L | -₹71.45L | ₹0.00L |
| Net Tangible Assets | ₹1,411.62L | ₹441.15L | -₹67.49L | -₹73.75L | ₹0.00L |
| Tangible Book Value | ₹1,411.62L | ₹441.15L | -₹67.49L | -₹73.75L | ₹0.00L |
| Current Liabilities | ₹203.30L | ₹75.67L | ₹72.69L | ₹92.12L | ₹0.00L |
| Stockholders Equity | ₹1,411.62L | ₹441.19L | -₹65.01L | -₹71.45L | ₹0.00L |
| Other Equity Interest | ₹253.33L | ₹507.25L | -₹588.90L | -₹595.34L | ₹0.00L |
| Total Capitalization | ₹1,416.58L | ₹441.19L | -₹65.01L | -₹71.45L | ₹0.00L |
| Ordinary Shares Number | ₹115.83L | ₹52.39L | ₹52.39L | ₹52.39L | ₹0.00L |
| Total Non Current Assets | ₹3.65L | ₹4.05L | ₹6.58L | ₹7.30L | ₹0.00L |
| Cash And Cash Equivalents | ₹122.36L | ₹248.24L | ₹0.25L | ₹0.03L | ₹0.00L |
| Other Short Term Investments | ₹734.97L | ₹0.00L | ₹0.00L | ₹0.01L | ₹0.01L |
| Other Non Current Liabilities | ₹0.04L | ₹0.00L | -₹0.01L | -₹0.01L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹1,411.62L | ₹441.19L | -₹65.01L | -₹71.45L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹208.40L | ₹75.77L | ₹73.15L | ₹92.59L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹28.13L | ₹4.96L | ₹35.21L | ₹35.21L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹4.96L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹857.33L | ₹248.24L | ₹0.25L | ₹0.03L | ₹0.00L |
| Total Non Current Liabilities Net Minority Interest | ₹5.10L | ₹0.10L | ₹0.46L | ₹0.47L | ₹0.00L |
Cash Flow
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Free Cash Flow | -₹1,099.59L | -₹229.02L | ₹0.22L | -₹0.31L | ₹0.00L |
| Changes In Cash | -₹125.86L | ₹247.99L | ₹0.22L | ₹0.00L | ₹0.00L |
| End Cash Position | ₹122.36L | ₹248.24L | ₹0.25L | ₹0.03L | ₹0.00L |
| Financing Cash Flow | ₹973.73L | ₹477.01L | ₹0.00L | ₹0.31L | ₹0.00L |
| Investing Cash Flow | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Operating Cash Flow | -₹1,099.59L | -₹229.02L | ₹0.22L | -₹0.31L | ₹0.00L |
| Beginning Cash Position | ₹248.24L | ₹0.25L | ₹0.03L | ₹0.03L | ₹0.00L |
| Issuance Of Capital Stock | ₹951.60L | ₹507.26L | ₹0.00L | ₹0.00L | ₹0.00L |
| Other Cash Adjustment Outside Changein Cash | -₹0.02L | ₹0.00L | ₹0.00L | ₹0.00L | -₹0.01L |
Income Statement
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| EBIT | ₹27.70L | -₹1.41L | -₹11.19L | ₹22.57L | ₹0.00L |
| EBITDA | ₹28.10L | -₹0.77L | -₹10.47L | ₹23.38L | ₹0.00L |
| Basic EPS | ₹0.00L | -₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income | ₹24.82L | -₹1.05L | ₹6.45L | ₹22.56L | ₹0.00L |
| Diluted EPS | ₹0.00L | -₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Gross Profit | ₹74.35L | ₹1.27L | ₹0.00L | -₹0.90L | ₹0.00L |
| Pretax Income | ₹27.70L | -₹1.41L | ₹8.69L | ₹22.57L | ₹0.00L |
| Tax Provision | ₹2.87L | -₹0.36L | ₹2.24L | ₹0.01L | ₹0.00L |
| Total Revenue | ₹802.49L | ₹80.73L | ₹0.00L | ₹0.00L | ₹0.00L |
| Cost Of Revenue | ₹728.14L | ₹79.46L | ₹0.00L | ₹0.90L | ₹0.00L |
| Total Expenses | ₹790.85L | ₹187.45L | ₹11.19L | ₹19.36L | ₹0.00L |
| Interest Expense | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Operating Income | ₹11.64L | -₹106.72L | -₹11.19L | -₹19.36L | ₹0.00L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Normalized EBITDA | ₹28.10L | -₹0.77L | -₹10.47L | ₹23.38L | ₹0.00L |
| Normalized Income | ₹24.82L | -₹1.05L | ₹6.45L | ₹22.56L | ₹0.00L |
| Operating Expense | ₹62.71L | ₹107.99L | ₹11.19L | ₹18.46L | ₹0.00L |
| Operating Revenue | ₹802.49L | ₹80.73L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Interest Income | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Basic Average Shares | ₹115.83L | ₹52.39L | ₹52.39L | ₹52.39L | ₹0.00L |
| Diluted Average Shares | ₹115.83L | ₹52.39L | ₹52.39L | ₹52.39L | ₹0.00L |
| Other Operating Expenses | ₹42.64L | ₹103.35L | ₹5.69L | ₹9.36L | ₹0.00L |
| Reconciled Depreciation | ₹0.40L | ₹0.64L | ₹0.72L | ₹0.80L | ₹0.00L |
| Reconciled Cost Of Revenue | ₹728.14L | ₹79.46L | ₹0.00L | ₹0.90L | ₹0.00L |
| Tax Effect Of Unusual Items | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Interest Expense Non Operating | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income Common Stockholders | ₹24.82L | -₹1.05L | ₹6.45L | ₹22.56L | ₹0.00L |
| Net Income Continuous Operations | ₹24.82L | -₹1.05L | ₹6.45L | ₹22.56L | ₹0.00L |
| Diluted NIAvailto Com Stockholders | ₹24.82L | -₹1.05L | ₹6.45L | ₹22.56L | ₹0.00L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Non Operating Interest Income Expense | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income Including Noncontrolling Interests | ₹24.82L | -₹1.05L | ₹6.45L | ₹22.56L | ₹0.00L |
| Net Income From Continuing And Discontinued Operation | ₹24.82L | -₹1.05L | ₹6.45L | ₹22.56L | ₹0.00L |
| Net Income From Continuing Operation Net Minority Interest | ₹24.82L | -₹1.05L | ₹6.45L | ₹22.56L | ₹0.00L |
Company Performance (FY25–FY26)
₹8.0 Cr₹6.0 Cr₹4.0 Cr₹2.0 Cr₹0
FY25FY26
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 16/01/2024 | Swapneswar Mishra | 09594775 | Director | View other directorships |
| 22/08/2024 | Dasi Reddy Rakesh | 07112785 | Director | View other directorships |
| 22/08/2024 | Gundluru Reddeppa | 10419527 | Director | View other directorships |
| 02/09/2024 | Sai Baba Kummarikuntla | *****4031H | CFO | |
| 01/10/2024 | Venkata Rao Sadhanala | 02906370 | Whole-time director | View other directorships |
| 26/04/2025 | Priyanka Agarwal | *****5550P | Company Secretary |
Business Network
CompanyDirectorNot on WeeDooBoard seatKey rolePast seatOwnership
Directors 6
- Venkata Rao SadhanalaWhole-time director
- Dasi Reddy RakeshDirector
- Gundluru ReddeppaDirector
- Swapneswar MishraDirector
- Priyanka AgarwalCompany Secretary
- Sai Baba KummarikuntlaCFO
Latest Documents
Category:
| Date | Title | Size |
|---|---|---|
| 25/11/2024 | Form AOC-4(XBRL)-22112024 | - |
| 14/11/2024 | Form MGT-7-14112024 | - |
| 12/11/2024 | Form MGT-7-28102024 | - |
| 10/11/2024 | Form AOC-4(XBRL)-02112024 | - |
| 16/10/2024 | Form MGT-7-01102024 | - |
Charges
| SRN | Date | Amount | Holder |
|---|---|---|---|
| B77361509 | 11/07/2008 | ₹1,50,00,000.00 | Union Bank Of India |
| A40745010 | 17/08/1999 | ₹1,42,95,000.00 | A.p. State Financial Corporation |
| A40813115 | 02/08/1999 | ₹70,00,000.00 | A.p. Industrial Development Corporation Ltd. |
| A40745572 | 20/08/1991 | ₹56,00,000.00 | A.p. State Financial Corporation |
| A40746588 | 13/08/1991 | ₹6,20,000.00 | A.p. State Financial Corporation |
| A40898017 | 15/07/1991 | ₹61,90,000.00 | State Bank Of India |
| A40895633 | 15/07/1991 | ₹44,00,000.00 | State Bank Of India |
| A40747289 | 09/04/1991 | ₹56,00,000.00 | A.p. State Financial Corporation |
| A40747610 | 16/03/1991 | ₹3,15,000.00 | A.p. State Financial Corporation |
| A40748063 | 09/05/1990 | ₹4,00,000.00 | A.p. State Financial Corporation |
| A40748568 | 03/05/1990 | ₹56,00,000.00 | A.p. State Financial Corporation |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Dabur India Limited | L24230DL1975PLC007908 | 8/3 Asaf Ali Road, New Delhi, Delhi, India, 110002 |
| Gujchem Distillers India Limited | L24230GJ1939PLC002480 | - |
| Ind Swift Limited | L24230CH1986PLC006897 | 781industrial Area Phase Ii, Chandigarh, Chandigarh, India, 160002 |
| Lyka Labs Limited | L24230GJ1976PLC008738 | 4801/b & 4802/a Gidc Indutrail Estate, Ankleshwar, Gujarat, India, 393002 |
| Torrent Pharmaceuticals Ltd | L24230GJ1972PLC002126 | Torrent Houseoff Ashram Road Navarangpura 9, Ahmedabad, Gujarat, India, 000000 |
Address
Sy. No. 115, Brig Sayeed Road, Hanumanji Colony, Bowenpally, Picket, Hyderabad, Secunderabad, Telangana, India, 500009
Frequently Asked Questions
What is the incorporation date of Venmax Drugs And Pharmaceuticals Limited?
The incorporation date of Venmax Drugs And Pharmaceuticals Limited is 28/09/1988.
What is the authorized share capital and paid-up capital of Venmax Drugs And Pharmaceuticals Limited?
The authorized share capital of Venmax Drugs And Pharmaceuticals Limited is ₹22,00,00,000.00. The paid-up capital is ₹8,00,79,300.00.
Who are the current board members & directors of Venmax Drugs And Pharmaceuticals Limited?
The current board member of Venmax Drugs And Pharmaceuticals Limited are:
- Priyanka Agarwal
- Sai Baba Kummarikuntla
- Swapneswar Mishra
- Venkata Rao Sadhanala
- Dasi Reddy Rakesh
- Gundluru Reddeppa
What is the registered address of Venmax Drugs And Pharmaceuticals Limited?
The registered address of Venmax Drugs And Pharmaceuticals Limited is Sy. No. 115, Brig Sayeed Road, Hanumanji Colony, Bowenpally, Picket, Hyderabad, Secunderabad, Telangana, India, 500009.
What is the Corporate Identification Number of Venmax Drugs And Pharmaceuticals Limited?
The Corporate Identification Number of Venmax Drugs And Pharmaceuticals Limited is L24230TG1988PLC009102.